Home    Back

Synthetic preimplantation factor    (DrugBank: Preimplantation factor, Synthetic PreImplantation Factor)

1 disease
IDDisease name (Link within this page)Number of trials
95Autoimmune hepatitis2

95. Autoimmune hepatitis    [ 44 clinical trials,   57 drugs,   (DrugBank: 26 drugs),   18 drug target genes,   108 drug target pathways]
Searched query = "Autoimmune hepatitis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
2 / 44 trials found
No.TrialIDDate_
enrollment		Date_
registration		Public_titleScientific_titleConditionInterventionPrimary_
sponsor		Secondary_
sponsor		Recruitment_
Status		Inclusion_
agemin		Inclusion_
agemax		Inclusion_
gender		Target_
size		PhaseCountries
1NCT03593460
(ClinicalTrials.gov)		January 1, 20197/6/2018Phase II AutoImmune HepatitisPhase II, Open Label, Adaptive Design, Multiple Dose Finding Study to Investigate Synthetic PreImplantation Factor (sPIF) in Patients With Autoimmune Hepatitis (AIH)Hepatitis, AutoimmuneDrug: Synthetic PreImplantation FactorChristopher O'Brien, MDBioIncept LLCWithdrawn18 Years75 YearsAll0Phase 2NULL
2NCT02239562
(ClinicalTrials.gov)		November 14, 201410/9/2014sPIF CLINICAL STUDY PROTOCOL IN AUTOIMMUNE HEPATITISA Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single and Multiple Ascending Dose Study to Investigate the Safety, Tolerability and Pharmacokinetics of Synthetic PreImplantation Factor (sPIF) in Autoimmune HepatitisAutoimmune HepatitisDrug: sPIF;Drug: PlaceboChristopher O'Brien, MDBioIncept LLCCompleted18 Years70 YearsFemale36Phase 1United States